The boards of Anheuser-Busch InBev and SABMiller plc have agreed in principle on the key terms of an offer by AB InBev to acquire rival brewer SABMiller. The companies said early Tuesday that under an increased offer from AB InBev, SABMiller shareholders would receive £44.00 per share ($68.11 U.S.
Teva Pharmaceutical Industries Ltd. has released dutasteride capsules 0.5 mg, a medication for enlarged prostate, in the United States.
QS/1 this week launched SharpRx, which the company described as the next generation of pharmacy management software.
California Gov. Jerry Brown has approved legislation to create a pathway for the substitution of interchangeable biologic drugs, a move applauded by Biotechnology Industry Organization (BIO).
This week, Galderma Laboratories expanded its therapeutic skin care roster with the launch of Excipial, a line of dermatologist-developed products formulated for “challenged skin.
Wahl Home Products has rolled out wearable technology that it calls a first in the area of pain management. The Wahl Clipper Corp.
Camber Pharmaceuticals has expanded its generic drug lineup with the release of clopidogrel tablets, an anticoagulant, and pramipexole dihydrocloride tablets, a treatment for Parkinson’s disease.
Topical BioMedics Inc. has landed retail distribution for its Topricin Pain Relief and Healing Cream at CVS/pharmacy. The company said CVS will carry the 4-ounce jar of Topricin Pain Relief and Healing Cream.
Beer giant Anheuser-Busch InBev has offered to buy fellow brewing behemoth SABMiller plc for $104 billion (U.S.) but saw its increased bid quickly rejected. AB InBev said Wednesday that it’s now offering £42.15 ($64.
Centrum is providing a more flavorful and convenient way to take a multivitamin. The Pfizer Consumer Healthcare brand has launched Centrum VitaMints, a minty, chewable multivitamin.
AmerisourceBergen Corp. plans to acquire PharMEDium Healthcare Holdings, Inc., a national provider of outsourced compounded sterile preparations (CSPs) to acute care hospitals, in a $2.575 billion cash deal.
Horizon Pharma plc is moving its U.S. corporate headquarters to a larger facility in Lake Forest, Ill., to accommodate its expanding organization. Horizon said Monday that the new office space, located at 150 South Saunders Rd. in Lake Forest, is about triple the size of its current U.S.
Cardinal Health has completed its acquisition of Johnson & Johnson’s Cordis cardiology and endovascular device business for $1.944 billion. Cardinal said Sunday evening that the integration of Cordis off to a strong start, with management teams in place worldwide.
Eos Products LLC has reached a settlement that stops a private-label manufacturer and its components supplier from selling knockoff versions of its egg-shaped lip balm. Eos said that OraLabs Inc.
Dr. Fresh LLC’s Reach oral care brand is bringing back an old friend to help promote its expanded Complete Care product lineup. The company said Thursday that Mr.
Nestlé has added to its lineup of treats this fall with the new Nestlé Crunch Peanuts character bars for Halloween and skull-and bone-shaped SweeTarts for Día de los Muertos. The chocolate maker said Wednesday that the Nestlé Crunch Peanuts Molded Fun Size Bars (suggested retail price of $3.
